KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Total Debt (2016 - 2025)

Historic Total Debt for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Charles River Laboratories International's Total Debt fell 606.88% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 606.88%. This contributed to the annual value of $2.2 billion for FY2024, which is 1537.29% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Total Debt is $2.2 billion, which was down 606.88% from $2.3 billion recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Total Debt registered a high of $3.0 billion during Q2 2022, and its lowest value of $2.2 billion during Q3 2025.
  • Over the past 5 years, Charles River Laboratories International's median Total Debt value was $2.7 billion (recorded in 2024), while the average stood at $2.6 billion.
  • Its Total Debt has fluctuated over the past 5 years, first soared by 4359.11% in 2021, then plummeted by 1537.29% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Total Debt (Quarter) stood at $2.7 billion in 2021, then increased by 1.54% to $2.7 billion in 2022, then dropped by 2.23% to $2.6 billion in 2023, then dropped by 15.37% to $2.2 billion in 2024, then decreased by 2.44% to $2.2 billion in 2025.
  • Its Total Debt was $2.2 billion in Q3 2025, compared to $2.3 billion in Q2 2025 and $2.5 billion in Q1 2025.